Of note, antibodies specifically raised against the Tau1–368 neoepitope were found in AD brains and absent in legumain knockout mice, thus validating in vivo legumain-mediated Tau processing (Zhang et al., 2014). The gene discussed is MAPT; the disease is Alzheimer disease.